Showing results (31-40 of 203) with videos related to
Sort By:
Pageof 21
Current Pharmaceutical Design|May 29, 2012
The TGF-β signaling pathway as a pharmacological target in a hepatocellular carcinomaAntonio Mazzocca, Salvatore Antonaci, Gianluigi GiannelliPlant Foods for Human Nutrition (Dordrecht, Netherlands)|July 13, 2022
The Edible Plant Crithmum maritimum Shows Nutraceutical Properties by Targeting Energy Metabolism in Hepatic CancerDavide Gnocchi, Carlo Sabbà, Antonio MazzoccaJournal of Experimental & Clinical Cancer Research : CR|May 13, 2010
Proton pump inhibitors as anti vacuolar-ATPases drugs: a novel anticancer strategyEnrico P Spugnini, Gennaro Citro, Stefano FaisJournal of Clinical Medicine|April 23, 2022
Chronic Inflammation in Obesity and Cancer CachexiaRosa Divella, Gennaro Gadaleta Caldarola, Antonio MazzoccaOncogene|December 17, 2003
Tetraspanin CD81 is linked to ERK/MAPKinase signaling by Shc in liver tumor cellsVinicio Carloni, Antonio Mazzocca, Kodimangalam S RavichandranCurrent Pharmaceutical Design|February 25, 2012
A rationale for the use of proton pump inhibitors as antineoplastic agentsAngelo De Milito, Maria Lucia Marino, Stefano FaisCancer Letters|December 3, 2014
Lansoprazole induces sensitivity to suboptimal doses of paclitaxel in human melanomaTommaso Azzarito, Giulietta Venturi, Albino Cesolini, et al.Nanomaterials (Basel, Switzerland)|April 27, 2026
Ayurvedic Medicinal Plants and Plant-Derived Extracellular Vesicles: Current Evidence and Future PerspectivesManasi Bhabal, Tiziana Pietrangelo, Mariantonia Logozzi, et al.Hepatology (Baltimore, Md.)|December 31, 2008
Targeting transforming growth factor (TGF)-betaRI inhibits activation of beta1 integrin and blocks vascular invasion in hepatocellular carcinomaEmilia Fransvea, Antonio Mazzocca, Salvatore Antonaci, et al.International Journal of Molecular Sciences|January 8, 2023
The Adaptability of Chromosomal Instability in Cancer Therapy and ResistanceVinicio Carloni, Elisa Morganti, Andrea Galli, et al.Pageof 21